Debasmita Dutta

5PUBLICATIONS
14CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsNanoscale characterisationMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2025
A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma.

Debasmita Dutta, Jiye Liu, Kenneth Wen

|Apr 30, 2025
Mechanistic Underpinnings of Epigenetic Enzyme-Responsive Nanoparticles.

Raj Shankar Hazra, Debasmita Dutta, Md Rakib Hasan Khan

|Aug 20, 2024
EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment.

Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul

|Apr 30, 2024
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.

Debasmita Dutta, Priyanka Ray, Archana De

|Dec 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma.

Debasmita Dutta, Jiye Liu, Kenneth Wen

Pageof 1

Frequent Collaborators

1 joint publications

Jiye Liu

1 joint publications

Keiji Kurata

1 joint publications

Mariateresa Fulciniti

1 joint publications

Kenneth C Anderson